Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Mar;43(3):297-302.
doi: 10.1002/ana.410430306.

Eye movement abnormalities correlate with genotype in autosomal dominant cerebellar ataxia type I

Affiliations
Review

Eye movement abnormalities correlate with genotype in autosomal dominant cerebellar ataxia type I

S Rivaud-Pechoux et al. Ann Neurol. 1998 Mar.

Abstract

We compared horizontal eye movements (visually guided saccades, antisaccades, and smooth pursuit) in control subjects (n = 14) and patients with three forms of autosomal dominant cerebellar ataxias type I: spinocerebellar ataxias 1 and 2 (SCA1, n = 11; SCA2, n = 10) and SCA3/Machado-Joseph disease (MJD) (n = 16). In SCA1, saccade amplitude was significantly increased, resulting in hypermetria. The smooth pursuit gain was decreased. In SCA2, saccade velocity was markedly decreased. The percentage of errors in antisaccades was greatly increased and was significantly correlated with age at disease onset. In addition, a correlation between smooth pursuit gain and the number of trinucleotide repeats was found. In SCA3, gaze-evoked nystagmus was often present as was saccade hypometria and smooth pursuit gain was markedly decreased. Three major criteria, saccade amplitude, saccade velocity, and presence of gaze-evoked nystagmus, permitted the correct assignment of 90% of the SCA1, 90% of the SCA2, and 93% of the patients with SCA3 to their genetically confirmed patient group and, therefore, may help orient diagnoses of SCA1, SCA2, and SCA3 at early clinical stages of the diseases.

PubMed Disclaimer

Similar articles

Cited by

  • Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions.
    Méreaux JL, Davoine CS, Pellerin D, Coarelli G, Coutelier M, Ewenczyk C, Monin ML, Anheim M, Le Ber I, Thobois S, Gobert F, Guillot-Noël L, Forlani S, Jornea L, Heinzmann A, Sangare A, Gaymard B, Guyant-Maréchal L, Charles P, Marelli C, Honnorat J, Degos B, Tison F, Sangla S, Simonetta-Moreau M, Salachas F, Tchikviladzé M, Castelnovo G, Mochel F, Klebe S, Castrioto A, Fenu S, Méneret A, Bourdain F, Wandzel M, Roth V, Bonnet C, Riant F, Stevanin G, Noël S, Fauret-Amsellem AL, Bahlo M, Lockhart PJ, Brais B, Renaud M, Brice A, Durr A. Méreaux JL, et al. EBioMedicine. 2024 Jan;99:104931. doi: 10.1016/j.ebiom.2023.104931. Epub 2023 Dec 27. EBioMedicine. 2024. PMID: 38150853 Free PMC article.
  • An overview of the patient with ataxia.
    Mariotti C, Fancellu R, Di Donato S. Mariotti C, et al. J Neurol. 2005 May;252(5):511-8. doi: 10.1007/s00415-005-0814-z. J Neurol. 2005. PMID: 15895274 Review.
  • Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1.
    Matilla-Dueñas A, Goold R, Giunti P. Matilla-Dueñas A, et al. Cerebellum. 2008;7(2):106-14. doi: 10.1007/s12311-008-0009-0. Cerebellum. 2008. PMID: 18418661 Review.
  • Vestibulo-ocular arreflexia in families with spinocerebellar ataxia type 3 (Machado-Joseph disease).
    Gordon CR, Joffe V, Vainstein G, Gadoth N. Gordon CR, et al. J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1403-6. doi: 10.1136/jnnp.74.10.1403. J Neurol Neurosurg Psychiatry. 2003. PMID: 14570834 Free PMC article.
  • Slow saccades in cerebellar disease.
    Jensen K, Beylergil SB, Shaikh AG. Jensen K, et al. Cerebellum Ataxias. 2019 Jan 17;6:1. doi: 10.1186/s40673-018-0095-9. eCollection 2019. Cerebellum Ataxias. 2019. PMID: 30680221 Free PMC article. Review.

Publication types

LinkOut - more resources